×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DNTH – dianthus therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DNTH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
06:08 am
dnth
Dianthus Therapeutics (DNTH) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Dianthus Therapeutics (DNTH) was upgraded by Wolfe Research to "strong-buy".
4/9
09:00 am
dnth
Dianthus Therapeutics (DNTH) is now covered by Wolfe Research. They set an "outperform" rating and a $98.00 price target on the stock.
Medium
Report
Dianthus Therapeutics (DNTH) is now covered by Wolfe Research. They set an "outperform" rating and a $98.00 price target on the stock.
4/6
04:01 pm
dnth
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/6
03:57 pm
dnth
Dianthus Therapeutics CFO Sells $9.5 Million in Stock [Yahoo! Finance]
Low
Report
Dianthus Therapeutics CFO Sells $9.5 Million in Stock [Yahoo! Finance]
4/3
01:23 am
dnth
How Investors May Respond To Dianthus Therapeutics (DNTH) Early “GO” Decision And FDA Backing For Claseprubart [Yahoo! Finance]
Low
Report
How Investors May Respond To Dianthus Therapeutics (DNTH) Early “GO” Decision And FDA Backing For Claseprubart [Yahoo! Finance]
4/1
05:02 am
dnth
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength? [Yahoo! Finance]
3/19
09:16 am
dnth
Dianthus Therapeutics (DNTH) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $135.00 price target on the stock.
Low
Report
Dianthus Therapeutics (DNTH) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $135.00 price target on the stock.
3/18
05:19 pm
dnth
Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP [Yahoo! Finance]
Low
Report
Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/9/2026
07:09 am
dnth
dianthus therapeutics, inc.
MISS
Report
-2.5%
dianthus therapeutics, inc.
11/5/2025
04:01 pm
dnth
dianthus therapeutics, inc.
MISS
Report
8.0%
dianthus therapeutics, inc.
5/12/2025
04:01 pm
dnth
dianthus therapeutics, inc.
BEAT
Report
-6.2%
dianthus therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/10
04:52 pm
dnth
Form 4 Dianthus Therapeutics, For: Apr 09 Filed by: Savitz Ryan
Low
Report
Form 4 Dianthus Therapeutics, For: Apr 09 Filed by: Savitz Ryan
4/9
04:23 pm
dnth
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Low
Report
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
4/9
04:12 pm
dnth
Form ARS Dianthus Therapeutics, For: Dec 31
Low
Report
Form ARS Dianthus Therapeutics, For: Dec 31
4/9
04:11 pm
dnth
Form DEFA14A Dianthus Therapeutics,
Low
Report
Form DEFA14A Dianthus Therapeutics,
4/9
04:09 pm
dnth
Form DEF 14A Dianthus Therapeutics, For: May 21
Medium
Report
Form DEF 14A Dianthus Therapeutics, For: May 21
4/1
05:27 pm
dnth
Form 4 Dianthus Therapeutics, For: Mar 31 Filed by: Savitz Ryan
Low
Report
Form 4 Dianthus Therapeutics, For: Mar 31 Filed by: Savitz Ryan
4/1
05:26 pm
dnth
Form 4 Dianthus Therapeutics, For: Mar 31 Filed by: Soteropoulos Paula
Low
Report
Form 4 Dianthus Therapeutics, For: Mar 31 Filed by: Soteropoulos Paula
3/31
04:25 pm
dnth
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Low
Report
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: